ArticleDiabetes2009

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.

Mohammad Hossein Noyan-Ashraf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.